tiprankstipranks
Portage Biotech Releases Q2 2024 Financials
Company Announcements

Portage Biotech Releases Q2 2024 Financials

Portage Biotech Inc (PRTG) has released an update.

Don't Miss our Black Friday Offers:

Portage Biotech Inc. has released its financial statements for the three months ending June 30, 2024, showing a calculated management of assets and liabilities. The unaudited report, prepared under International Financial Reporting Standards, indicates a reduction in total assets and shareholders’ equity compared to the previous quarter. The company’s expenses, including research and development as well as general and administrative expenses, have led to a loss from operations, despite a positive change in the fair value of warrant liability.

For further insights into PRTG stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskPortage Biotech Welcomes New Financial Leadership
TipRanks Auto-Generated NewsdeskPortage Biotech Regains Nasdaq Compliance
TipRanks Auto-Generated NewsdeskPortage Biotech Reports Decreased Quarterly Loss
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App